Exponent (EXPO) Stock Forecast, Price & News

Exponent (NASDAQ:EXPO) Frequently Asked Questions

Is Exponent a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Exponent stock.
View analyst ratings for Exponent or view top-rated stocks.

Are investors shorting Exponent?

Exponent saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,140,000 shares, an increase of 35.3% from the April 30th total of 842,500 shares. Based on an average daily volume of 308,900 shares, the days-to-cover ratio is presently 3.7 days. Currently, 2.2% of the company's shares are short sold.
View Exponent's Short Interest.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Exponent.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) posted its quarterly earnings results on Thursday, April, 28th. The business services provider reported $0.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.04. The business services provider earned $117.90 million during the quarter, compared to analysts' expectations of $115.50 million. Exponent had a trailing twelve-month return on equity of 25.02% and a net margin of 20.90%. The company's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.58 earnings per share.
View Exponent's earnings history.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Thursday, April 28th. Shareholders of record on Friday, June 10th will be paid a dividend of $0.24 per share on Friday, June 24th. This represents a $0.96 dividend on an annualized basis and a yield of 1.06%. The ex-dividend date of this dividend is Thursday, June 9th.
View Exponent's dividend history.

Is Exponent a good dividend stock?

Exponent pays an annual dividend of $0.96 per share and currently has a dividend yield of 1.07%. Exponent has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Exponent is 51.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Exponent will have a dividend payout ratio of 47.29% next year. This indicates that Exponent will be able to sustain or increase its dividend.
View Exponent's dividend history.

When did Exponent's stock split? How did Exponent's stock split work?

Exponent shares split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly issued shares were issued to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

1 Wall Street analysts have issued 12-month target prices for Exponent's stock. Their forecasts range from $120.00 to $120.00. On average, they expect Exponent's share price to reach $120.00 in the next year. This suggests a possible upside of 32.0% from the stock's current price.
View analysts' price targets for Exponent or view top-rated stocks among Wall Street analysts.

Who are Exponent's key executives?

Exponent's management team includes the following people:

• Dr. Catherine Ford Corrigan P.E., Ph.D., Pres, CEO & Director (Age 53, Pay $1.36M)
• Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 56, Pay $982.64k)
• Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E., Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director (Age 53, Pay $818.97k) (LinkedIn Profile)
• Dr. Bradley A. James Ph.D., P.E., FASM, Corp. VP, Principal Engineer & Practice Director- Materials & Corrosion Engineering (Age 56, Pay $737.77k)
• Dr. Steven J. Murray P.E., Ph.D., Group VP & Principal Engineer (Age 47, Pay $773.93k) (LinkedIn Profile)
• Dr. Bernard Ross, Co-Founder, Chairman Emeritus & Principal Engineer
• Dr. Subbaiah V. Malladi, CTO & Principal Engineer (Age 75)
• Ms. Sally B. Shepard, Chief HR Officer (Age 61)
• Mr. Eric R. Anderson, VP & Corp. Controller
• Dr. Robert D. Caligiuri FASM, P.E., Ph.D., Corp. VP of Materials & Corrosion Engineering and Principal Engineer (Age 70)

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent CEO Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among Exponent's employees.

Who are some of Exponent's key competitors?

Some companies that are related to Exponent include Verisk Analytics (VRSK), Equifax (EFX), Nielsen (NLSN), Dun & Bradstreet (DNB), FTI Consulting (FCN), CBIZ (CBZ), ICF International (ICFI), Huron Consulting Group (HURN), CRA International (CRAI), Franklin Covey (FC), VSE (VSEC), Acacia Research (ACTG), Mistras Group (MG) and Odyssey Marine Exploration (OMEX).
View all of EXPO's competitors.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.18%), Vanguard Group Inc. (10.89%), Neuberger Berman Group LLC (5.92%), Conestoga Capital Advisors LLC (4.61%), State Street Corp (3.25%) and Geneva Capital Management LLC (2.40%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, George H Brown, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends for Exponent.

Which major investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Polen Capital Management LLC, Assenagon Asset Management S.A., Goldman Sachs Group Inc., Raymond James & Associates, Arrowstreet Capital Limited Partnership, TD Asset Management Inc., and Neuberger Berman Group LLC. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Carol Lindstrom, Harri Kytomaa, Maureen T F Reitman, Paul R Johnston, and Steven J Murray.
View insider buying and selling activity for Exponent or view top insider-selling stocks.

Which major investors are buying Exponent stock?

EXPO stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, State Street Corp, Riverbridge Partners LLC, BlackRock Inc., RK Capital Management LLC, Laurus Investment Counsel Inc., Comerica Bank, and Royal Bank of Canada.
View insider buying and selling activity for Exponent or or view top insider-buying stocks.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $90.88.

How much money does Exponent make?

Exponent has a market capitalization of $4.71 billion and generates $466.27 million in revenue each year. The business services provider earns $101.20 million in net income (profit) each year or $1.879990 on an earnings per share basis.

How many employees does Exponent have?

Exponent employs 1,215 workers across the globe.

Does Exponent have any subsidiaries?

The following companies are subsidiares of Exponent: Dennis Publishing.

When was Exponent founded?

Exponent was founded in 1967.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at (650) 326-9400, via email at [email protected], or via fax at 650-326-8072.